Replimune’s RP1+nivolumab melanoma BLA faces an FDA decision by Apr 10, 2026. The current cash runway extends to Q1'27. See ...
Brain slice electrophysiology, immunohistochemistry, and in vivo two-photon calcium imaging identify circuit dysfunction and epilepsy mechanism in a Kcnc1-A421V/+ mouse model of developmental and ...
Discover how the prisoner's dilemma helps businesses find a balance between competition and cooperation for improved outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results